André Andonian, Flagship chair of Asia Pacific and senior advisor
November 7, 2023 05:00 PM ESTUpdated November 11, 01:48 AM
Financing
Startups
Bioregnum

Flag­ship Pi­o­neer­ing takes an­oth­er big step across the globe, plant­i­ng its biotech flag in Asia

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Who pays the most in bio­phar­ma? We an­a­lyzed me­di­an pay at 177 com­pa­nies

Fed­er­al judge sides with FDA on its mifepri­s­tone safe­ty pro­gram

Up­dat­ed: Mer­ck drops $10B for res­pi­ra­to­ry drug­mak­er Verona Phar­ma in its first ac­qui­si­tion of 2025

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Q&A: Re­tir­ing Arv­inas CEO John Hous­ton talks PRO­TACs, in­vestor con­fi­dence and what’s next with Pfiz­er

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times